Pfizer Archives - DelveInsight

Pfizer

recent-pharma-news-and-updates-for-Pfizer-Forte-Biosciences- Bone-Therapeutics-Versanis-Bio-AC-Immune
Pfizer’s RSV Vaccine; Forte Biosciences’ Atopic Dermatitis Asset; Bone Therapeutics’ Osteoarthrit...

Pfizer’s RSV Vaccine enters in the late-stage of clinical trials As the battle to get an effective Respiratory Syncytial Virus (RSV) vaccine on the market heats up, Pfizer is launching a ...


top-pharma-biotech-companies-by-revenue-share-drugs-therapies-2020-2021-worldwide
Top 7 Pharma Industry Leaders in 2020 By the Numbers

Pharmaceutical companies play a vital part in our lives and in helping us to live healthier lives. The pharmaceutical industry finds, develops, manufactures, and promotes medicines or pharmaceutic...


Sinusitis-Disease-Overview-Signs-and-Treatments
Sinusitis: Something More Troublesome Than Just Cold

Cold can make anyone cheerless and miserable, however, having Sinusitis is another story. Also known as rhinosinusitis, Sinusitis makes a person suffer from a stuffy nose, blocked nasal passages, ...


hemophilia-b-market
Hemophilia B Market: How Pipeline Therapies are Transforming the Treatment Hemisphere?

An X-linked recessive disorder, Hemophilia occurs predominantly in males with females being the carriers. Patients diagnosed with Hemophilia usually lack one of the two proteins essential for the ...


Chronic Pain Market Landscape | Chronic Pain Pipeline | Osteoarthritis
Emerging Therapies in the Chronic Pain Pipeline Transforming the Chronic Pain Market Landscape

More than 100 million people are living with one or the other form of Chronic Pain in the USA, says the Institute of Medicine. The available treatments to tackle cancer, as well as non-cancer pain...


Aurinia's Lupkynis for Lupus; Toripalimab; Merck’s Covid-19 Vaccines fail
Aurinia’s Lupkynis for Lupus; FDA Fast Track Designation for Toripalimab; Wren Therapeutics...

Hot on the heels, Aurinia launches its drug in the Lupus market after GSKAurinia Pharmaceuticals has recently got the USFDA approval for its Lupkynis (voclosporin) in combination with a backgr...


Pfizer’s Somatrogon; SCONE device; ATG-010; SanBio in Neurology
Pfizer/ OPKO Health’s Somatrogon; FDA EU for SCONE device; Antengene ATG-010 for rrMM and rrDLBCL...

Pfizer and OPKO Health: A step closer to FDA Nod for pediatric growth hormone deficiency (GHD) drug, SomatrogonPfizer and Opko had joined hands in 2014 to develop somatrogon, a pediatric growt...


Myovant Pfizer Deal_Generic for Severe Hypoglycemia_Teleflex
A USD 4.2 Billion Myovant/ Pfizer Deal; Audentes Therapeutics’ ASPIRO Trial Free to Proceed; Firs...

A USD 4.2 Billion Myovant/ Pfizer DealMyovant Sciences have decided to put their forces and efforts together to advance the Prostate cancer market as they announced their partnership deal to d...


Historic win for Pfizer's COVID-19 Vaccine; Alexion Buyout; and more
FTA for Gannex’s ASC4; Disappointment for Incyte’s Ruxolitinib; Historic win for Pfizer, BioNTech...

Gannex received US FDA fast track designation for its NASH drug, ASC42 an FXR AgonistGannex Pharma has received Fast Track designation approval from FDA for its drug candidate ASC42 for non-al...


recent-pharma-happenings-for-pfizer-sanofi-elevation-oncology
Pfizer succeeds COVID-19 vaccine safety milestone; Sanofi snags speedy review for BTK drug; Autoi...

Pfizer succeeds COVID-19 vaccine safety milestonePfizer prepares to file its COVID-19 vaccine for emergency use authorization (EUA) after succeeding a key safety breakthrough. Pfizer now has t...


Editor's Pick
Healthcare Data Breach: What it Means for Companies and the Consumer?

Data and analytics today are playing a major role in the organization’s growth. Stakeho...

Onychomycosis Therapy Market Set to Balloon Up as Emerging Novel Therapies Co...

Onychomycosis is the most commonly prevalent nail infection in adults. It is a fungal i...

Angelman syndrome Pipeline: Unmet needs call for a robust pipeline

The necessity of a robust Angelman syndrome pipeline is indispensable at the current mo...

The New Buzz of Transcranial Stimulation Devices in the Neurological Disorder...

Neurological disorders are one of the major causes of death and disability across the g...

Leading Autoimmune Diseases to Undergo Robust Improvement in Treatment by Maj...

As per the American Autoimmune Related Diseases Association (AARDA), nearly 50 million ...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.